Constellation Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Constellation Pharmaceuticals Ownership

Who owns Constellation Pharmaceuticals?

Constellation Pharmaceuticals is owned by MorphoSys AG. It was acquired on June 2, 2021.

Constellation Pharmaceuticals Business Overview

Where is Constellation Pharmaceuticals headquartered?

Constellation Pharmaceuticals is headquartered in Cambridge, Massachusetts.

How many employees does Constellation Pharmaceuticals have?

Constellation Pharmaceuticals has 154 employees.

What sector is Constellation Pharmaceuticals in?

Constellation Pharmaceuticals is a life science company.

When was Constellation Pharmaceuticals founded?

Constellation Pharmaceuticals was founded in 2008.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 391 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 345 by strategics.

Constellation Pharmaceuticals

Constellation Pharmaceuticals, Inc.

215 First Street Suite 200,
Cambridge, Massachusetts 02142
United States,
(617) 714-0555
www.constellationpharma.com

Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with various forms of cancer. Constellation Pharmaceuticals was founded in 2008 and is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 206,067
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.